Pharmaceuticals and Biotech | Media Room

Press Release Oct 19, 2023

Brad Stefanovic, Clinical Operations and Innovation Leader, Joins Pro-ficiency

Press Release Oct 18, 2023

Trust.med Aims to Eliminate Counterfeit Drugs From Pharmaceutical Supply Chain With Launch of Its Contact and Verification Registry

Commonsense Online and Mobile Approach to Identifying and Engaging With Drug Manufacturers to Meet DSCSA Requirements — Including Drop Shipment Transactions Read More

Press Release Oct 17, 2023

Rancho Biosciences Earns Prestigious 'Great Place to Work' Certification for the Second Consecutive Year

Press Release Oct 17, 2023

Moolec Science Announces Capital Raise With Strategic Investors for ~US $30 Million

Press Release Oct 16, 2023

Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars

New biologics outsourcing solution provider leverages proven track record of Tanvex BioPharma USA Inc. to help early-stage companies bring mammalian and microbial derived biologics from concept to commercialization. Read More

Press Release Oct 12, 2023

Aronora Secures Investment From New York Blood Center

Aronora is Revolutionizing Blood Clot Treatment with Groundbreaking Innovations Read More

Press Release Oct 12, 2023

National Survey Reveals Americans Saving $5,000 a Year by Ordering Prescriptions From Canada

93% Say Prescription Drug Costs Are Important to How They’ll Vote in the Next Election, Compared to 84% a Year Ago Read More

Press Release Oct 11, 2023

Insight Therapeutics Announces Major Expansion in Research Capabilities

Press Release Oct 10, 2023

Rancho BioSciences to Showcase CDISC Data Services at the 2023 CDISC US Interchange

Press Release Oct 9, 2023

Germfree Laboratories and AST Unite to Redefine Aseptic Fill-Finish Processing Technology

Revolutionary Collaboration to Introduce an American-Made Turn-Key Solution with Unparalleled Innovation Read More

Press Release Oct 5, 2023

Senzo Secures an Additional $1.8m Investment for Its Novel Rapid Home-Test Diagnostic Platform

Senzo Health Limited (London, UK) ("Senzo"), a life sciences company developing high-accuracy, low-cost, point-of-care diagnostic technologies, this week announced an additional $1.8m investment for its breakthrough Amplified Lateral Flow (ALF) test technology, advancing its mission to bring high-quality, affordable tests into the home. Read More

Press Release Oct 5, 2023

Auxilius Completes SOC 1 Type 2 Certification

Rigorous Audit Validates Auxilius as a Trusted Clinical Trial Financial Management Platform, a Key Element of Compliance and Assurance of Controls for the Highly Regulated Life Sciences Industry Read More

Press Release Oct 4, 2023

CorDx to Launch New Global Brand, CuPet, in Singapore

Press Release Oct 4, 2023

ADHD Online to Share Individual Stories Daily & Host Webinars for ADHD Awareness Month

The leader in ADHD assessments will feature a series of podcasts and webinars covering ADHD resources, insights, discussions, destigmatization efforts for this condition, and the pursuit of optimal ADHD treatment. Read More

Press Release Oct 4, 2023

XiltriX North America Announces SOC 2 Type 1 Certification for Enhanced Security and Compliance of Its Monitoring-as-a-Service Solution

Press Release Oct 3, 2023

A New Publication Highlights the Use of cResponse in the Assessment of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer

A recent publication in "Cancer Discovery" reviewed Germline BRCA-associated pancreatic ductal adenocarcinoma (glBRCA PDAC) spectrum of responses to platinum and PARPi therapy, exploring the genomic and clinical features that may lead to different responses, and investigates the mechanisms of resistance. Read More

Press Release Oct 3, 2023

Flightpath Biosciences and the Forsyth Institute Enter Into Co-Development Agreement Targeting Oral Disease

Press Release Oct 3, 2023

The Immunoglobulin National Society and ACHC Announce Partnership

Press Release Oct 3, 2023

HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101

Press Release Oct 3, 2023

Introducing the ONI Discovery Kit (TM): dSTORM in Cells

Prepare for super-resolution Read More

Press Release Oct 2, 2023

Rancho Biosciences to Showcase Cutting-Edge Data Science Services at BioTechX Europe’s Largest Pharmaceutical Development and Healthcare Event, Oct. 4-6

Press Release Oct 2, 2023

PharmaLink Launches a DSCSA Compliant Solution for Retail and Hospital Markets

Press Release Sep 28, 2023

Seraxis to Provide Oral Update on Its Pancreatic Organoid Candidate for Functional Cure of T1D at the 59th Annual Meeting of the EASD

Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well as review initial diabetes model data of functional cure of Type 1 Diabetes. Seraxis’ presentation, entitled “Stem-cell Derived Islets for Treating Diabetes”, will be delivered in the session entitled "Transplantation of Islet and Stem Cells Today and Tomorrow". Read More

Press Release Sep 28, 2023

Rancho Biosciences Will Be Exhibiting at the Festival of Genomics & Biodata 2023

Press Release Sep 28, 2023

Amplity Health Appoints Kevin Murphy as New Head of Account Development

Appointment comes during accelerating growth of Amplity’s leading global medical and commercial franchise Read More

Press Release Sep 27, 2023

Live Forever Health Launches www.liveforeverlab.com: the Ultimate Destination for Comprehensive Lifestyle, Wellness, Hormone, and Fitness Solutions

Press Release Sep 27, 2023

Announcing Kivo GO: An Intuitive DMS to Accelerate Speed-to-Market for Life Sciences

Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams. Read More

Press Release Sep 27, 2023

Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs

Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy. Read More

Press Release Sep 26, 2023

Rancho BioSciences Collaborates to Standardize UK Biobank Clinical Data for Improved Genetic Analysis

Press Release Sep 21, 2023

Unboxed Training & Technology Receives LTEN Excellence Award for Learning Content

Press Release Sep 21, 2023

Seraxis Announces Closing of Second VC Tranche and Successful Completion of Preclinical Studies of Pancreatic Organoids From Seraxis’ Novel Pancreas-Derived Stem Cells

Leadership team expanded with addition of Chief Corporate Development Officer, Ted Hibben, a 25-year venture-stage business development biotherapeutic industry veteran Total venture funding tops $50M to date Read More

Press Release Sep 19, 2023

First Patient Treated in Innovative Clinical Study 'Amelia-1', Testing the Novel Investigational Drug Evexomostat Plus a PI3K Inhibitor in Late-Stage Breast Cancer Patients

Amelia™-1 Study is testing if evexomostat can improve patients' safety and clinical response to a PI3K inhibitor plus an estrogen receptor degrader. Evexomostat, a novel MetAP2 inhibitor, controlled PI3K-induced hyperglycemia in the first study patient, consistent with pre-clinical data. Further, ctDNA data shows no evidence of residual PIK3CA mutation in blood after 6 weeks of treatment. Read More

Press Release Sep 19, 2023

Nostics Appoints Medtech Leader Jeroen Nieuwenhuis as CEO

Press Release Sep 19, 2023

Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery

Press Release Sep 19, 2023

LighthouseAI Introduces Automated Business Change Management to Simplify Pharmaceutical Supply Chain Compliance

New Module Automates Regulatory Updates During Corporate Transitions Read More

Press Release Sep 14, 2023

SciTech Development Announces IRB Approval for Human Clinical Trials

Lead cancer drug candidate, ST-001 nanoFenretinide, has received Institutional Review Board ("IRB") approval for its upcoming clinical trials for T-Cell Lymphomas. Read More

Press Release Sep 14, 2023

New Cell & Gene Therapy Solutions From Form Bio Analyze Billions of Potential Construct Candidates, Reducing Time-to-Clinic

Powerful New Solutions Help Therapeutic Developers Reduce Time-to-Clinic While Increasing Yield and Safety Read More

Press Release Sep 13, 2023

Serve You Rx Transforms Pharmacy Benefit Management With New Client-Centered Branding Strategy

Pharmacy benefit manager's new brand pillars leverage strengths to better serve their partners and clients. Read More

Press Release Sep 12, 2023

New US Prescription Drugs Cost Now More Than $200K on Average

Ongoing rise in customers ordering Rx medication from Pharmacies like Canada Pharmacy Read More

Press Release Sep 12, 2023

CARDIO inCode Study Results Presented at ESC Annual Meeting

Coronary Heart Disease (CHD) prevention nearly twice as effective when using CARDIO inCode as method to target treatment Read More

Press Release Sep 12, 2023

Brainify.AI Joins Johnson & Johnson Innovation JLABS

Brainify.AI, an innovative company leveraging artificial intelligence to revolutionize the treatment of depression, is excited to announce it has joined Johnson & Johnson Innovation JLABS (JLABS) as a resident company. This marks a significant milestone for Brainify.AI and is another indication of the value and promise the company brings to the medical AI field. Read More

Press Release Sep 11, 2023

Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research

Press Release Sep 7, 2023

Introducing the ONI Training Kit (TM) dSTORM

A leap into simplifying Super-Resolution Microscopy Read More

Press Release Sep 6, 2023

Minaris Regenerative Medicine Selects Apprentice.io's Tempo Manufacturing Execution System to Scale Commercial Production

Press Release Sep 5, 2023

Milestone Achievement: Waypoint GPS Assists Dr. Stephen Banco in Groundbreaking First-in-Man Spine Surgery

Press Release Sep 5, 2023

Tribun Health Secures €15 Million Euros in Series B Funding Round Led by Autonomous Patient Fund of Bpifrance With LBO, Owkin and Vivalto Family as Prominent Investors

Press Release Aug 30, 2023

Healing the Wounds of Inflammatory Bowel Disease

A University of Chicago team identified a special type of stem cell that heals damaged bowel tissue in mice, a discovery that may have direct application to humans with inflammatory bowel disease. These early findings, made possible with seed funding from the GI Research Foundation, resulted in a recent five-year, $2.5 million grant from the National Institutes of Health to study those cells in humans. Read More

Press Release Aug 28, 2023

HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies

Press Release Aug 25, 2023

Ischemix, Inc. Completes Successful Phase 1 Trial of Novel Compound to Treat Traumatic Brain Injury (TBI); Preparing for Conduct of Phase 2 Trial

CMX-2043, a novel, proprietary cytoprotective drug candidate, demonstrated excellent safety and tolerability in a Phase 1 single ascending and multiple ascending dose (SAD-MAD) clinical trial. CMX-2043 has previously demonstrated safety and efficacy in extensive preclinical pharmacology, toxicology and TBI translational studies. CMX-2043 will be Phase 2-ready by the first quarter of 2024. Read More

Press Release Aug 24, 2023

Granger Health Announces Acquisition of Medical Device and Data Analytics Company

Press Release Aug 24, 2023

assisTek Announces Updated CORE Platform Release for Fall 2023

PA-based clinical technology provider assisTek has announced new features to its upcoming software release, including AI Integration, a Proprietary OS, SSO & Remote Provisioning, to add to its growing suite of eCOA & ePRO solutions. Read More

Press Release Aug 22, 2023

Enalare Therapeutics Selected to Present at Three Upcoming Scientific Conferences Regarding Its Lead Compound, ENA-001

Press Release Aug 18, 2023

Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a Phase 2/3 Clinical Trial Evaluating Nexagon for the Treatment of Persistent Corneal Epithelial Defects

Press Release Aug 17, 2023

WholisticResearch Reveals the Best Nootropics of 2023

In-depth Analysis and Testing Unveil the Leading Brain-Boosting Supplements Read More

Press Release Aug 17, 2023

Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians Read More

Press Release Aug 16, 2023

For the 3rd Year in a Row, Just in Time GCP Makes the Inc. 5000, Ranking No. 2813

Just in Time GCP named among Best Workplaces by Inc. Magazine Read More

Press Release Aug 16, 2023

Native Cardio Inc. Welcomes Steve Adler as New CEO — Medical Device Company Poised to Enter the Atrial Fibrillation Market

Press Release Aug 16, 2023

Eden Radioisotopes, LLC Notifies the US Nuclear Regulatory Commission of Plans to Submit License Applications to Construct and Operate a Medical Isotope Production Facility

Press Release Aug 15, 2023

Apprentice Announces Major Tempo Manufacturing Cloud Release Built to Support Commercial Manufacturing of the Future

Updates to Tempo's Manufacturing Execution System and Connected Manufacturing Network Drive Greater Efficiency and Scalability Read More

Press Release Aug 15, 2023

Form Bio Announces Executive Webinar Featuring BCG, ElevateBio, and NVIDIA

Data Science Meets Life Science: AI Challenges & Opportunities in Biopharma, Synthetic Biology and Beyond Read More